Success Metrics

Clinical Success Rate
94.1%

Based on 192 completed trials

Completion Rate
94%(192/204)
Active Trials
92(23%)
Results Posted
10%(20 trials)
Terminated
12(3%)

Phase Distribution

Ph phase_4
3
1%
Ph phase_3
3
1%
Ph not_applicable
19
5%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution25 total trials
Phase 3Large-scale testing
3(12.0%)
Phase 4Post-market surveillance
3(12.0%)
N/ANon-phased studies
19(76.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.9%

192 of 209 finished

Non-Completion Rate

8.1%

17 ended early

Currently Active

92

trials recruiting

Total Trials

392

all time

Status Distribution
Active(111)
Completed(192)
Terminated(17)
Other(72)

Detailed Status

Completed192
Recruiting75
unknown72
Not yet recruiting17
Active, not recruiting17
Terminated12

Development Timeline

Analytics

Development Status

Total Trials
392
Active
92
Success Rate
94.1%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (12.0%)
Phase 43 (12.0%)
N/A19 (76.0%)

Trials by Status

enrolling_by_invitation21%
completed19249%
recruiting7519%
not_yet_recruiting174%
unknown7218%
withdrawn51%
active_not_recruiting174%
terminated123%

Recent Activity

Clinical Trials (392)

Showing 20 of 392 trialsScroll for more
NCT02883725

National Register of Oesophageal Atresia

Completed
NCT04387656

NCI COVID-19 in Cancer Patients, NCCAPS Study

Active Not Recruiting
NCT07215611

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

Recruiting
NCT00684580

Protocol For Collecting Data On Patients With Childhood Cancer

Recruiting
NCT05650619

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Recruiting
NCT03390751

Atropine Weight and Risk of Postoperative Confusion in the Elderly

Completed
NCT07529730

Outcomes of Surgical Treatment in Patients With Infective Endocarditis

Completed
NCT05439044

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Completed
NCT05692596

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

Active Not Recruiting
NCT04477681

Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

Recruiting
NCT07499141

Use of Fluorescence in Gliomas

Completed
NCT07375069

Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy

Recruiting
NCT07305961

National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of Scabies

Completed
NCT06560476

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Recruiting
NCT04703114Not Applicable

Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV)

Completed
NCT04578509

Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva

Completed
NCT07010562

A Multi-site, Pre-clinical, Prospective Data Collection Study in Patients Undergoing a Right Heart Catheterization

Not Yet Recruiting
NCT05781893

Basel Long COVID-19 Cohort Study and Digital Long COVID Substudy

Active Not Recruiting
NCT04831125

Conduction System Pacing International Registry (CONSPIRE)

Completed
NCT04423484

Therapeutic Recommendations for Nephroblastoma

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
392